Legal & General Group Plc Decreases Position in Allogene Therapeutics, Inc. (NASDAQ:ALLO)
Legal & General Group Plc trimmed its stake in Allogene Therapeutics, Inc. (NASDAQ:ALLO – Free Report) by 11.9% in the fourth quarter, HoldingsChannel.com reports. The fund owned 112,235 shares of the company’s stock after selling 15,172 shares during the quarter. Legal & General Group Plc’s holdings in Allogene Therapeutics were worth $239,000 at the end […]
Legal & General Group Plc trimmed its stake in Allogene Therapeutics, Inc. (NASDAQ:ALLO – Free Report) by 11.9% in the fourth quarter, HoldingsChannel.com reports. The fund owned 112,235 shares of the company’s stock after selling 15,172 shares during the quarter. Legal & General Group Plc’s holdings in Allogene Therapeutics were worth $239,000 at the end […]
